McCully Belinda H, Connelly Christopher R, Fair Kelly A, Holcomb John B, Fox Erin E, Wade Charles E, Bulger Eileen M, Schreiber Martin A
Division of Trauma, Critical Care and Acute Care Surgery, Department of Surgery, Oregon Health & Science University, Portland, OR Center for Translational Injury Research, Division of Acute Care Surgery, Department of Surgery, University of Texas Health Science Center, Houston, TX Division of Trauma and Critical Care, Department of Surgery, University of Washington, Seattle, WA.
J Am Coll Surg. 2017 Jul;225(1):42-51. doi: 10.1016/j.jamcollsurg.2017.03.001. Epub 2017 Mar 16.
Altered coagulation function after trauma can contribute to development of venous thromboembolism (VTE). Severe trauma impairs coagulation function, but the trajectory for recovery is not known. We hypothesized that enhanced, early recovery of coagulation function increases VTE risk in severely injured trauma patients.
Secondary analysis was performed on data from the Pragmatic Randomized Optimal Platelet and Plasma Ratio (PROPPR) trial, excluding patients who died within 24 hours or were on pre-injury anticoagulants. Patient characteristics, adverse outcomes, and parameters of platelet function and coagulation (thromboelastography) were compared from admission to 72 hours between VTE (n = 83) and non-VTE (n = 475) patients. A p value < 0.05 indicates significance.
Despite similar patient demographics, VTE patients exhibited hypercoagulable thromboelastography parameters and enhanced platelet function at admission (p < 0.05). Both groups exhibited hypocoagulable thromboelastography parameters, platelet dysfunction, and suppressed clot lysis (low clot lysis at 30 minutes) 2 hours after admission (p < 0.05). The VTE patients exhibited delayed coagulation recovery (a significant change compared with 2 hours) of K-value (48 vs 24 hours), α-angle (no recovery), maximum amplitude (24 vs 12 hours), and clot lysis at 30 minutes (48 vs 12 hours). Platelet function recovery mediated by arachidonic acid (72 vs 4 hours), ADP (72 vs 12 hours), and collagen (48 vs 12 hours) was delayed in VTE patients. The VTE patients had lower mortality (4% vs 13%; p < 0.05), but fewer hospital-free days (0 days [interquartile range 0 to 8 days] vs 10 days [interquartile range 0 to 20 days]; p < 0.05) and higher complication rates (p < 0.05).
Recovery from platelet dysfunction and coagulopathy after severe trauma were delayed in VTE patients. Suppressed clot lysis and compensatory mechanisms associated with altered coagulation that can potentiate VTE formation require additional investigation.
创伤后凝血功能改变可促使静脉血栓栓塞症(VTE)的发生。严重创伤会损害凝血功能,但恢复轨迹尚不清楚。我们推测,严重受伤的创伤患者凝血功能早期恢复增强会增加VTE风险。
对实用随机优化血小板与血浆比例(PROPPR)试验的数据进行二次分析,排除在24小时内死亡或受伤前使用抗凝剂的患者。比较VTE患者(n = 83)和非VTE患者(n = 475)从入院到72小时的患者特征、不良结局以及血小板功能和凝血参数(血栓弹力图)。p值<0.05表示具有显著性。
尽管患者人口统计学特征相似,但VTE患者入院时血栓弹力图参数显示高凝状态,血小板功能增强(p < 0.05)。两组在入院2小时后均表现为血栓弹力图参数低凝、血小板功能障碍和凝血块溶解受抑制(30分钟时凝血块溶解率低)(p < 0.05)。VTE患者的K值(48小时与24小时)、α角(无恢复)、最大振幅(24小时与12小时)以及30分钟时的凝血块溶解(48小时与12小时)的凝血恢复延迟(与2小时相比有显著变化)。VTE患者由花生四烯酸(72小时与4小时)、二磷酸腺苷(72小时与12小时)和胶原(48小时与12小时)介导的血小板功能恢复延迟。VTE患者死亡率较低(4%对13%;p < 0.05),但无住院天数较少(0天[四分位间距0至8天]对10天[四分位间距0至20天];p < 0.05),并发症发生率较高(p < 0.05)。
VTE患者严重创伤后血小板功能障碍和凝血病的恢复延迟。与凝血改变相关的凝血块溶解受抑制和代偿机制可增强VTE形成,这需要进一步研究。